"From our nationally renowned oncologists to some of the field's leading research scientists, patients at West Cancer Center & Research Institute are surrounded by a team of cancer experts and incredible support services throughout their cancer journey and beyond."

During the past decade, Memphis Cancer Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memphis Cancer Center" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Prologue Research International" with 2 trials sponsored, "Sanofi" with 2 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored and "Delcath Systems Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memphis Cancer Center" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Emory University" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Memphis Cancer Center" are "Colorectal Cancer" (5 trials), "Breast Cancer" (2 trials), "Bile Duct Cancer" (1 trials), "Chemotherapy Effect" (1 trials) and "Hormone-Refractory Prostate Cancer" (1 trials). Many other conditions were trialed in "Memphis Cancer Center" in a lesser frequency.

Most popular intervention types in "Memphis Cancer Center" are "Drug" (13 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "oxaliplatin" (4 trials), "Ipatasertib" (3 trials), "Bevacizumab" (2 trials) and "fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Memphis Cancer Center" are 12 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Memphis Cancer Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Memphis Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Memphis Cancer Center, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".